Patients with hepatobiliary cancer exhibited the highest GDF-15 levels (median 6,233 ng/L; Q1-Q3: 3,285-9,861 ng/L), whereas patients with brain tumors had the lowest levels (median 858 ng/L; Q1-Q3: 522-1,150 ng/L). The gene discussed is GDF15; the disease is brain neoplasm.